Rick Stewart, the former chief executive at clinical research firm Amarin who left the company at the beginning of the year, received a total package worth €1.5m in 2007, according to the company's annual report. The 2007 report states that the payment included an $804,000 termination payment and bonus, and $21,000 in untaken holiday payments. He also received other expenses of $75,000 and $8,000 in pension entitlements. This compared with $815,000 in 2006. Tom Lynch, chairman and chief executive, received a package worth $872,000, up from $482,000. The company's share price collapsed last summer after trials of its Miraxion treatment for Huntington's disease failed to show any significant benefits. But the shares gained ground later in the year after it emerged that the company could get the green light for a new drug...
[read full story]